71 related articles for article (PubMed ID: 25945970)
1. Myelography iodinated contrast media. I. Unraveling the atropisomerism properties in solution.
Fontanive L; D'Amelio N; Cesàro A; Gamini A; Tavagnacco L; Paolantoni M; Brady JW; Maiocchi A; Uggeri F
Mol Pharm; 2015 Jun; 12(6):1939-50. PubMed ID: 25945970
[TBL] [Abstract][Full Text] [Related]
2. Myelography Iodinated Contrast Media. 2. Conformational Versatility of Iopamidol in the Solid State.
Bellich B; Di Fonzo S; Tavagnacco L; Paolantoni M; Masciovecchio C; Bertolotti F; Giannini G; De Zorzi R; Geremia S; Maiocchi A; Uggeri F; Masciocchi N; Cesàro A
Mol Pharm; 2017 Feb; 14(2):468-477. PubMed ID: 28059514
[TBL] [Abstract][Full Text] [Related]
3. Multistep approach for the structural identification of biotransformation products of iodinated X-ray contrast media by liquid chromatography/hybrid triple quadrupole linear ion trap mass spectrometry and (1)H and (13)C nuclear magnetic resonance.
Kormos JL; Schulz M; Wagner M; Ternes TA
Anal Chem; 2009 Nov; 81(22):9216-24. PubMed ID: 19842634
[TBL] [Abstract][Full Text] [Related]
4. [Stability of iodinated contrast media in UV-laser irradiation and toxicity of the photoproducts].
Grönewäller EF; Wahl HG; Kehlbach R; Rodemann HP; Claussen CD; Duda SH
Rofo; 1998 Nov; 169(5):537-41. PubMed ID: 9849607
[TBL] [Abstract][Full Text] [Related]
5. Kinetic study of photocatalytic degradation of carbamazepine, clofibric acid, iomeprol and iopromide assisted by different TiO2 materials--determination of intermediates and reaction pathways.
Doll TE; Frimmel FH
Water Res; 2004 Feb; 38(4):955-64. PubMed ID: 14769415
[TBL] [Abstract][Full Text] [Related]
6. Advanced oxidation of iodinated X-ray contrast media in reverse osmosis brines: the influence of quenching.
Azerrad SP; Gur-Reznik S; Heller-Grossman L; Dosoretz CG
Water Res; 2014 Oct; 62():107-16. PubMed ID: 24945978
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of the hydrophilic sphere of iobitridol, an iodinated contrast agent, as revealed by experimental and computational investigations.
Meyer D; Fouchet MH; Petta M; Carrupt PA; Gaillard P; Testa B
Pharm Res; 1995 Nov; 12(11):1583-91. PubMed ID: 8592654
[TBL] [Abstract][Full Text] [Related]
8. A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH.
Moon BF; Jones KM; Chen LQ; Liu P; Randtke EA; Howison CM; Pagel MD
Contrast Media Mol Imaging; 2015; 10(6):446-55. PubMed ID: 26108564
[TBL] [Abstract][Full Text] [Related]
9. Ozonation and reductive deiodination of iopromide to reduce the environmental burden of iodinated X-ray contrast media.
Putschew A; Miehe U; Tellez AS; Jekel M
Water Sci Technol; 2007; 56(11):159-65. PubMed ID: 18057654
[TBL] [Abstract][Full Text] [Related]
10. Abiotic reductive deiodination of iodinated organic compounds and X-ray contrast media catalyzed by free corrinoids.
El-Athman F; Adrian L; Jekel M; Putschew A
Chemosphere; 2019 Apr; 221():212-218. PubMed ID: 30640003
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of the hydrophilic sphere of iobitridol, a new nonionic iodinated contrast agent.
Meyer D; Petta M; Fouchet MH; Vadel M; Schaefer M; Dugast-Zrihen M; Guillemot M
Acta Radiol Suppl; 1996; 400():8-16. PubMed ID: 8619359
[TBL] [Abstract][Full Text] [Related]
12. Formation of oxidation by-products of the iodinated X-ray contrast medium iomeprol during ozonation.
Seitz W; Jiang JQ; Schulz W; Weber WH; Maier D; Maier M
Chemosphere; 2008 Jan; 70(7):1238-46. PubMed ID: 17892892
[TBL] [Abstract][Full Text] [Related]
13. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations.
Gallotti A; Uggeri F; Favilla A; Cabrini M; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S1-12. PubMed ID: 8020510
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of iodinated X-ray contrast media and their biotransformation products in the urban water cycle.
Kormos JL; Schulz M; Ternes TA
Environ Sci Technol; 2011 Oct; 45(20):8723-32. PubMed ID: 21877755
[TBL] [Abstract][Full Text] [Related]
15. Borate complexes of x-ray iodinated contrast agents: characterization and sorption studies for their removal from aqueous media.
Rustighi I; Donati I; Ferluga M; Campa C; Pasqua AE; Rossi M; Paoletti S
J Hazard Mater; 2012 Feb; 205-206():10-6. PubMed ID: 22245510
[TBL] [Abstract][Full Text] [Related]
16. FT-IR, FT-Raman, NMR and UV-Vis spectra and DFT calculations of 5-bromo-2-ethoxyphenylboronic acid (monomer and dimer structures).
Sas EB; Kose E; Kurt M; Karabacak M
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():1315-33. PubMed ID: 25305625
[TBL] [Abstract][Full Text] [Related]
17. Atropisomerism in Drug Discovery: A Medicinal Chemistry Perspective Inspired by Atropisomeric Class I PI3K Inhibitors.
Perreault S; Chandrasekhar J; Patel L
Acc Chem Res; 2022 Sep; 55(18):2581-2593. PubMed ID: 36069734
[TBL] [Abstract][Full Text] [Related]
18. Contrast timing in computed tomography: effect of different contrast media concentrations on bolus geometry.
Mahnken AH; Jost G; Seidensticker P; Kuhl C; Pietsch H
Eur J Radiol; 2012 Apr; 81(4):e629-32. PubMed ID: 22297184
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of phototransformation reactions of the X-ray contrast medium iopromide under simulated solar radiation using UPLC-ESI-QqTOF-MS.
Pérez S; Eichhorn P; Ceballos V; Barceló D
J Mass Spectrom; 2009 Sep; 44(9):1308-17. PubMed ID: 19565538
[TBL] [Abstract][Full Text] [Related]
20. Dehalogenation of iodinated X-ray contrast media in a bioelectrochemical system.
Mu Y; Radjenovic J; Shen J; Rozendal RA; Rabaey K; Keller J
Environ Sci Technol; 2011 Jan; 45(2):782-8. PubMed ID: 21141818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
